<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: CYCCP News</title><copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=cyccp</link><description>Latest Financial News for Cyclacel Pharmaceuticals, Inc.</description><language>en-us</language><lastBuildDate>Tue, 15 Dec 2009 21:05:00 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>Cyclacel Receives NASDAQ Notice of Non-Compliance (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091215/180358.html?.v=1</link><description>BERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. today announced that, on December 9, 2009, the Company was notified by the NASDAQ Staff that the Company does not comply with the minimum $10 million stockholders&apos; equity requirement set forth in NASDAQ Listing Rule 5450 and that the Company&apos;s securities are subject to delisting from The Nasdaq Global Market unless the Company requests a hearing before a NASDAQ Listing Qualifications Panel .</description><guid isPermaLink="false">yahoo_finance/3255156037</guid><pubDate>Tue, 15 Dec 2009 21:05:00 Etc/GMT</pubDate></item><item><title>Cyclacel Provides Update on Meeting With FDA to Discuss Pivotal Study Design for Sapacitabine (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091215/180311.html?.v=1</link><description>BERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. announced today that the Company recently held a Type A meeting with the U.S. Food and Drug Administration to discuss a randomized Phase 3 study design for Cyclacel&apos;s oral sapacitabine capsules in acute myeloid leukemia and separately in myelodysplastic syndromes .</description><guid isPermaLink="false">yahoo_finance/4011706580</guid><pubDate>Tue, 15 Dec 2009 12:00:00 Etc/GMT</pubDate></item><item><title>Cyclacel Reports Phase 2 Sapacitabine Data in Acute Myeloid Leukemia and Myelodysplastic Syndromes at 2009 ASH Annual Meeting (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091205/179744.html?.v=1</link><description>BERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. announced today 1-year survival data from a Phase 2 randomized trial of oral sapacitabine capsules, a novel nucleoside analogue, in elderly patients with acute myeloid leukemia and separately interim response data in myelodysplastic syndromes .</description><guid isPermaLink="false">yahoo_finance/763018443</guid><pubDate>Sat, 5 Dec 2009 15:00:00 Etc/GMT</pubDate></item><item><title>Cyclacel to Host Conference Call on Monday, December 7 to Discuss New Phase 2 Sapacitabine Data to be Presented at ASH (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091201/179420.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2381622062</guid><pubDate>Tue, 1 Dec 2009 17:00:00 Etc/GMT</pubDate></item><item><title>Sapacitabine Phase 1 Data Published in Acute Leukemia and Myelodysplastic Syndromes (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091130/179269.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/95985736</guid><pubDate>Mon, 30 Nov 2009 14:00:00 Etc/GMT</pubDate></item><item><title>Cyclacel Pharmaceuticals to Present Sapacitabine Phase 2 AML &amp; MDS Data at the Upcoming American Society of Hematology Meeting (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091117/178570.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/4152019729</guid><pubDate>Tue, 17 Nov 2009 12:00:00 Etc/GMT</pubDate></item><item><title>Cyclacel Pharmaceuticals Announces Third Quarter 2009 Financial Results (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091103/177360.html?.v=1</link><description>BERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. announced today financial and operating results for the third quarter of 2009. The Company&apos;s net loss for the quarter was $3.1 million or $0.13 per share.</description><guid isPermaLink="false">yahoo_finance/55895976</guid><pubDate>Tue, 3 Nov 2009 21:01:00 Etc/GMT</pubDate></item><item><title>Cyclacel Pharmaceuticals Receives Deficiency Notice From Nasdaq Global Select Market (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091030/177069.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/36108735</guid><pubDate>Fri, 30 Oct 2009 20:05:00 Etc/GMT</pubDate></item><item><title>Cyclacel Pharmaceuticals Reports Survival Data From Phase 2 Sapacitabine Study in Elderly Patients With Acute Myeloid Leukemia (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091028/176786.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1844496683</guid><pubDate>Wed, 28 Oct 2009 20:12:29 Etc/GMT</pubDate></item><item><title>Cyclacel Pharmaceuticals Third Quarter 2009 Financial Results Conference Call On Tuesday November 3 &amp; Upcoming Conference Presentations (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091028/176706.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/606072659</guid><pubDate>Wed, 28 Oct 2009 11:00:00 Etc/GMT</pubDate></item><item><title>Cyclacel Pharmaceuticals to Present at BIO Investor Forum (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091021/175999.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2177825255</guid><pubDate>Wed, 21 Oct 2009 11:00:00 Etc/GMT</pubDate></item><item><title>Cyclacel to Present At Annual Rodman &amp; Renshaw Healthcare Conference (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090903/172586.html?.v=2</link><description></description><guid isPermaLink="false">yahoo_finance/1343850059</guid><pubDate>Thu, 3 Sep 2009 20:01:00 Etc/GMT</pubDate></item><item><title>Cyclacel Pharmaceuticals Announces Receipt of NASDAQ Notice (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090828/172240.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3687263029</guid><pubDate>Fri, 28 Aug 2009 20:01:00 Etc/GMT</pubDate></item><item><title>Cyclacel Pharmaceuticals Announces Second Quarter 2009 Financial Results (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090806/170895.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3663404099</guid><pubDate>Thu, 6 Aug 2009 20:01:00 Etc/GMT</pubDate></item><item><title>Cyclacel Pharmaceuticals to Announce Second Quarter 2009 Financial Results On August 6, 2009 (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090731/170378.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/343832908</guid><pubDate>Fri, 31 Jul 2009 20:30:00 Etc/GMT</pubDate></item><item><title>Cyclacel Completes Previously Announced Registered Direct Offering (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090730/170236.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/218648144</guid><pubDate>Thu, 30 Jul 2009 11:00:00 Etc/GMT</pubDate></item><item><title>Cyclacel to Raise Up to $5.9 Million in Registered Direct Offering (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090724/169756.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3338237712</guid><pubDate>Fri, 24 Jul 2009 12:30:00 Etc/GMT</pubDate></item><item><title>Cyclacel to Present At Annual Needham Biotechnology and Medical Technology Conference (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090609/166935.html?.v=3</link><description></description><guid isPermaLink="false">yahoo_finance/2154196298</guid><pubDate>Tue, 9 Jun 2009 13:30:00 Etc/GMT</pubDate></item><item><title>Sapacitabine Has Anti-Cancer Activity in Combination With Targeted Agents and Other Nucleoside Analogs (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090608/166861.html?.v=3</link><description></description><guid isPermaLink="false">yahoo_finance/3174653667</guid><pubDate>Mon, 8 Jun 2009 14:19:28 Etc/GMT</pubDate></item><item><title>Cyclacel Reports Initial Phase 2 Seliciclib Data in Patients With Nasopharyngeal Carcinoma At 2009 ASCO Annual Meeting (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090529/166328.html?.v=4</link><description></description><guid isPermaLink="false">yahoo_finance/859343362</guid><pubDate>Fri, 29 May 2009 19:00:00 Etc/GMT</pubDate></item></channel></rss><!-- c18.finance.sp2.yahoo.com compressed/chunked Sun Dec 27 19:33:09 PST 2009 -->
